A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis againstPneumocystis cariniiPneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection

Carlos López Bernaldo de Quirós, Juan; M. Miró, José; M. Peña, José; Podzamczer, Daniel; Alberdi, J.; Martínez, Estebán; Cosín, Jaime; Claramonte, Xavier; González, Juan; Domingo, Peré; L. Casado, José; Ribera, Esteban

doi:10.1056/nejm200101183440301

Public

A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis againstPneumocystis cariniiPneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection

Published in New England Journal of Medicine • Jan 18, 2001

Authors:

Juan Carlos López Bernaldo de Quirós

José M. Miró

José M. Peña

Abstract

BACKGROUND: Prophylaxis against Pneumocystis carinii pneumonia is indicated in patients with human immunodeficiency virus (HIV) infection who have less than 200 CD4 cells per cubic millimeter and in those with a history of P. carinii pneumonia. However, it is not clear whether prophylaxis can be saf...

Subject

Medicine

Pneumocystis carinii

Discontinuation

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!